Full Answer
Why has Cresco Labs stock fallen 36 percent from its peak?
Cresco Labs stock has fallen 36 percent from its peak. One of the reasons is the overall drop in marijuana and growth stocks due to the rotation in equity markets from growth to value. The soaring valuations have led to pressure on marijuana stocks.
What is Cresco Labs and how does it work?
Founded in 2013, Cresco Labs is a marijuana company in the U.S., with facilities in 10 states. The company has 18 processing and manufacturing plants, 44 retail store licenses, and 32 owned dispensaries.
What is the upside for Cresco Labs'stock?
Their forecasts range from $19.00 to $36.00. On average, they anticipate Cresco Labs' share price to reach $26.80 in the next year. This suggests a possible upside of 296.4% from the stock's current price.
What are analysts'price targets for Cresco Labs'stock?
8 Wall Street analysts have issued 12 month price targets for Cresco Labs' shares. Their forecasts range from $4.20 to $34.00. On average, they anticipate Cresco Labs' stock price to reach $19.74 in the next year. This suggests a possible upside of 69.3% from the stock's current price.
See more
What happened to Cresco Labs?
Cresco Labs, Inc. is a publicly traded, vertically integrated cannabis and medical marijuana company based in Chicago, Illinois, with current retail operations in nine states where marijuana has been legalized for medical use....Cresco Labs.TypePublicFounded2013FounderCharlie Bachtell Joe CaltabianoHeadquartersChicago, IL7 more rows
How high will Cresco Labs stock go?
Stock Price Forecast The 17 analysts offering 12-month price forecasts for Cresco Labs Inc have a median target of 11.71, with a high estimate of 24.19 and a low estimate of 3.90. The median estimate represents a +208.85% increase from the last price of 3.79.
Is Cresco Labs a Buy Sell or Hold?
Cresco Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.
What happened to Cresco?
Origin House was a cannabis distributor that Cresco Labs acquired back in 2019 for around 66.5 million shares which equates to $536 million based on today's share price. When the deal closed, Cresco Labs was then selling into over 575 dispensaries (65% penetration in California market) with 13 third-party brands.
Is Curaleaf a good stock to buy?
Despite having a remarkable growth in revenue, Curaleaf is not profitable yet. The company saw a 48% year-over-year growth in Q4 adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) to $80 million. For the full year, adjusted EBITDA jumped 107% to $298 million.
What is the future of Tilray stock?
The average one-year Tilray share price forecast is $10.31 a potential upside of 28%. The high price target is set at $23, while the low is at $6. According to the algorithm-based forecasting website WalletInvestor on 6 April, the stock could continue to decline and in 12 months' time fall to $5.3.
What is the price target for Crlbf?
Stock Price TargetHigh$24.19Low$3.90Average$12.31Current Price$3.7900
Is Crlbf a buy Zacks?
- CRLBF - Stock Price Today - Zacks....(Delayed Data from OTC)Zacks RankDefinitionAnnualized Return1Strong Buy25.08%2Buy18.56%3Hold10.15%4Sell5.79%2 more rows
Is Crlbf a good buy Zacks?
A value under 20 is generally considered good....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return5Strong Sell2.83%S&P50011.24%4 more rows
What does Cresco stand for?
cresco is an Latin word started with c. Here is the definition of cresco in English cresco cresco, crescere, crevi, cretus. verb come forth/to be; arise/spring (from); be born; become visible/great; grow (up); cresco. (cretum) to grow, increase, expand / spring forth, arise.
Who did Cresco buy?
Columbia Care IncMarch 23 (Reuters) - Cresco Labs Inc (CL.CD) is buying rival Columbia Care Inc (CCHW. NLB) in a $2-billion deal to become the top U.S. cannabis producer in one of the biggest deals in the industry.
What brands does Cresco own?
Sunnyside. Sunnyside is Cresco Labs' national retail brand where cannabis meets wellness. ... Cresco. ... Mindy's Chef Led Artisanal Edibles. ... Remedi. ... High Supply. ... Good News. ... Wonder Wellness Co. ... FloraCal Farms.More items...
Is Cresco Labs a buy right now?
7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are current...
Are investors shorting Cresco Labs?
Cresco Labs saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 867,900 shares, a drop of 35.0%...
When is Cresco Labs' next earnings date?
Cresco Labs is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for Cresco...
What price target have analysts set for CRLBF?
7 brokerages have issued 12-month price objectives for Cresco Labs' stock. Their forecasts range from $5.00 to $36.00. On average, they expect Cres...
Who are Cresco Labs' key executives?
Cresco Labs' management team includes the following people: Mr. Charles Bachtell , Co-Founder, CEO & Director (Age 42, Pay $537.5k) Mr. Dennis M...
Who are some of Cresco Labs' key competitors?
Some companies that are related to Cresco Labs include Tilray (TLRY) , Canopy Growth (CGC) , USANA Health Sciences (USNA) , Cronos Group (CRON)...
What is Cresco Labs' stock symbol?
Cresco Labs trades on the OTCMKTS under the ticker symbol "CRLBF."
How do I buy shares of Cresco Labs?
Shares of CRLBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBu...
What is Cresco Labs' stock price today?
One share of CRLBF stock can currently be purchased for approximately $3.74.
Key Points
The study examined more than 33,000 young adults and found that heart attacks were more frequent among cannabis users.
OTC: CRLBF
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
What happened
Shares of the medical marijuana company Cresco Labs ( CRLBF -4.46% ) had fallen roughly 12% this week, as of 2:35 p.m. EDT, for no obvious reason other than negative sentiment in the broader sector.
So what
The main reason marijuana stocks seem to be struggling has to do with a recent report from the Canadian Medical Association Journal that found a link between the use of marijuana and heart attacks.
Now what
Cresco recently completed the acquisition of Cultivate, a Massachusetts cannabis cultivator, and not too long ago reported earnings results for the second quarter that handily beat estimates from analysts.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
Marijuana stocks were a big disappointment in 2021
Rich has been a Fool since 1998 and writing for the site since 2004. After 20 years of patrolling the mean streets of suburbia, he hung up his badge and gun to take up a pen full time.
Acquisitions are a budding opportunity
Cresco Labs certainly has a lot working for it in its favor. In November, it closed on its acquisition of Cure Pennsylvania, which added three dispensaries to its portfolio.
Multipronged growth strategy
What helps set Cresco apart from many of its rivals is its leading wholesale business. Although wholesale cannabis is lower margin than retail sales, it can make up for that with volume.
Rocket in flight?
Investors would do well to consider the business and not the stock price since if a company is successful, its share price will likely follow over time.
What is MarketBeat community ratings?
MarketBeat's community ratings are surveys of what our community members think about Cresco Labs and other stocks. Vote “Outperform” if you believe CRLBF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CRLBF will underperform the S&P 500 over the long term. You may vote once every thirty days.
What is Cresco Labs?
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; flowers, popcorns, shakes, pre-rolls, and vapes under the High Supply brand; flowers, vapes, and edibles under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, ingestibles, sublingual oils, and transdermal patches under the Remedi brand, as well as cannabis products made from plants under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. It owns and operates 32 dispensaries, as well as 44 retail licenses. The company is headquartered in Chicago, Illinois.
When will Cresco Labs release its earnings?
Cresco Labs is scheduled to release its next quarterly earnings announcement on Wednesday, August 18th 2021. View our earnings forecast for Cresco Labs.
Does Cresco pay dividends?
Cresco Labs does not currently pay a dividend.
Is Cresco Labs a buy?
Cresco Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.
How many facilities does Cresco have?
One of the big advantages for Cresco is that it has control over the entire process as the company has 23 production facilities and 22 dispensaries across multiple states (including acquisitions still pending approval). From cultivation to the in-store experience, Cresco can provide customers with consistent, high-quality products and services. It's something that many other cannabis companies can't do because they typically control only one part of the process.
Does Cresco educate users?
Cresco also makes an effort to educate users so that they are making the best decisions possible. On the company's website, the company has a substantial amount of information on various different subjects, ranging from generic information to different ways to consume cannabis as well as links related to medical marijuana research and studies that have been done.
Is Cresco Labs a multistate company?
Chicago-based Cresco Labs has been steadily expanding its reach across the country and is slowly becoming a large, multistate operator. Last month, the company released its latest quarterly results, which showed tremendous sales growth, with revenues of $29.9 million rising by 253% from the $8.5 million in sales it generated in the prior year.
How long has Corey been a journalist?
He has more than 10 years of experience as a journalist and content creator. Since 2012, Corey’s work has been featured in major publications such as The Virginian-Pilot, The Washington Post, CNN, MSNBC and more.
What is bad credit?
Companies with bad credit. A company with little to no profits. Companies that provide less accounting information than regular exchanges. These are much smaller companies and your investments will give you a larger stake in the business.
What is Cresco Labs?
Cresco Labs Mission and Products. It’s Cresco’s mission to “normalize, professionalize and revolutionize cannabis.”. And the company has made major strides forward due to legalization efforts across the country. Cresco Labs stock is sure to benefit from the cannabis boom that isn’t going anywhere anytime soon.
What is the ticker symbol for stock?
In addition, the stock trades in over-the-counter (OTC) markets in the United States under the ticker symbol CRLBF. An over-the-counter market, or off-exchange, is trading done directly between two parties without the supervision of an exchange. And nearly 50% of all stock trades were made off-exchange in 2020.
What are the risks of buying OTC stocks?
However, it’s important to understand the risks of buying OTC stocks. These companies generally trade over-the-counter for a variety of reasons. For example, these reasons may include: 1 A new company that was just created 2 Companies with bad credit 3 A company with little to no profits 4 Companies that provide less accounting information than regular exchanges
Where is Cresco Labs located?
Cresco Labs was founded in 2013 and it’s currently headquartered in Chicago, Illinois. The business, much like other pot stocks, has taken advantage of the ever-growing list of states to legalize marijuana.
Is Cresco stock going anywhere?
Cresco Labs stock is sure to benefit from the cannabis boom that isn’t going anywhere anytime soon. But the company also has a range of products that consumers love. From edibles to softgels, you can find many Cresco brands at dispensaries and retail locations in various states.